Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1992 1
1993 1
1994 1
1995 1
2001 1
2004 1
2006 1
2008 2
2010 3
2011 5
2012 4
2013 2
2014 2
2015 3
2019 2
2020 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20RJ, 5BAuthor
Page 1
Quality of recovery following childbirth: a prospective, multicentre cohort study.
O'Carroll JE, Zucco L, Warwick E, Arbane G, Moonesinghe SR, El-Boghdadly K, Guo N, Carvalho B, Sultan P; ObsQoR Collaborators. O'Carroll JE, et al. Anaesthesia. 2023 Sep;78(9):1071-1080. doi: 10.1111/anae.16039. Epub 2023 May 24. Anaesthesia. 2023. PMID: 37226593
The following outcomes were reported: obstetric quality of recovery 10-item measure (ObsQoR-10); EuroQoL (EQ-5D-5L) survey; global health visual analogue scale; postpartum pain scores at rest and movement; length of hospital stay; readmission rates; and self-reported compl …
The following outcomes were reported: obstetric quality of recovery 10-item measure (ObsQoR-10); EuroQoL (EQ-5D-5L) survey; global he …
Genotype-specific variation in seasonal body condition at a large-effect maturation locus.
House AH, Debes PV, Kurko J, Erkinaro J, Primmer CR. House AH, et al. Proc Biol Sci. 2023 May 31;290(1999):20230432. doi: 10.1098/rspb.2023.0432. Epub 2023 May 31. Proc Biol Sci. 2023. PMID: 37253427
Earlier studies found a transcription cofactor, vgll3, associating with maturation timing that inhibits adipogenesis in mice and affects body condition in juvenile salmon. Owing to a lack of temporal studies examining seasonality effects on phenotypes such as vgll3 genotyp …
Earlier studies found a transcription cofactor, vgll3, associating with maturation timing that inhibits adipogenesis in mice and affects bod …
Atlantic salmon Salmo salar and ballan wrasse Labrus bergylta display different susceptibility to clonal strains of Paramoeba perurans.
Dahle OMV, Blindheim SH, Nylund A, Karlsbakk E, Breck O, Glosvik H, Andersen L. Dahle OMV, et al. Dis Aquat Organ. 2020 Jul 2;140:55-72. doi: 10.3354/dao03483. Dis Aquat Organ. 2020. PMID: 32614331 Free article.
Amoebic gill disease (AGD), caused by the marine amoeba Paramoeba perurans, is an important disease of farmed Atlantic salmon Salmo salar L. in Norway. The use of wrasse as cleaner fish in salmon net pens raises questions about interspecies transmissio …
Amoebic gill disease (AGD), caused by the marine amoeba Paramoeba perurans, is an important disease of farmed Atlantic salmon Salm …
Pilchard orthomyxovirus (POMV). II. Causative agent of salmon orthomyxoviral necrosis, a new disease of farmed Atlantic salmon Salmo salar.
Godwin SE, Morrison RN, Knowles G, Cornish MC, Hayes D, Carson J. Godwin SE, et al. Dis Aquat Organ. 2020 Apr 30;139:51-68. doi: 10.3354/dao03469. Dis Aquat Organ. 2020. PMID: 32351236
Since 2012, an orthomyxo-like virus has been consistently linked to epizootics in marine farmed Atlantic salmon in Tasmania, Australia. Here we describe the properties of the virus, designated the pilchard orthomyxovirus (POMV), in cell culture and present data verifying i …
Since 2012, an orthomyxo-like virus has been consistently linked to epizootics in marine farmed Atlantic salmon in Tasmania, Australi …
Daily endocrine profiles in parr and smolt Atlantic salmon.
Ebbesson LO, Björnsson BT, Ekström P, Stefansson SO. Ebbesson LO, et al. Comp Biochem Physiol A Mol Integr Physiol. 2008 Dec;151(4):698-704. doi: 10.1016/j.cbpa.2008.08.017. Epub 2008 Aug 24. Comp Biochem Physiol A Mol Integr Physiol. 2008. PMID: 18790069
To elucidate possible mechanisms behind the endocrine control of parr-smolt transformation, the daily plasma profiles in thyroid hormones (TH; free thyroxine (FT(4)), total thyroxine (TT(4)), and total 3,5,3'-triiodothyronine (TT(3))), growth hormone (GH) and cortisol were studie …
To elucidate possible mechanisms behind the endocrine control of parr-smolt transformation, the daily plasma profiles in thyroid hormones (T …
Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial.
Hammond NE, Finfer SR, Li Q, Taylor C, Cohen J, Arabi Y, Bellomo R, Billot L, Harward M, Joyce C, McArthur C, Myburgh J, Perner A, Rajbhandari D, Rhodes A, Thompson K, Webb S, Venkatesh B; ADRENAL Trial Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Hammond NE, et al. Intensive Care Med. 2020 Sep;46(9):1696-1706. doi: 10.1007/s00134-020-06169-1. Epub 2020 Jul 16. Intensive Care Med. 2020. PMID: 32676679
Of these 2151 patients (85.3%-1080 hydrocortisone and 1071 placebo) completed 6-month follow-up. Overall, at 6 months the mean EQ-5D-5L visual analogue scale (VAS) was 70.8, mean utility score 59.4. ...Bacteraemia was not associated with worse HRQoL in any domains of the E …
Of these 2151 patients (85.3%-1080 hydrocortisone and 1071 placebo) completed 6-month follow-up. Overall, at 6 months the mean EQ-5D- …
Ethnicity, socio-economic deprivation and postpartum outcomes following caesarean delivery: a multicentre cohort study.
O'Carroll JE, Zucco L, Warwick E, Radcliffe G, Moonesinghe SR, El-Boghdadly K, Guo N, Carvalho B, Sultan P; ObsQoR Collaborators. O'Carroll JE, et al. Anaesthesia. 2024 May;79(5):486-497. doi: 10.1111/anae.16241. Epub 2024 Feb 15. Anaesthesia. 2024. PMID: 38359531
Patients completed postpartum quality of life and recovery measures in person on day 1 (EuroQoL EQ-5D-5L, including global health visual analogue scale; Obstetric Quality of Recovery-10 item score; and pain scores) and by telephone between day 28 and day 32 postpartum (EQ- …
Patients completed postpartum quality of life and recovery measures in person on day 1 (EuroQoL EQ-5D-5L, including global health vis …
The agreement between proxy and self-completed EQ-5D for care home residents was better for index scores than individual domains.
Devine A, Taylor SJ, Spencer A, Diaz-Ordaz K, Eldridge S, Underwood M. Devine A, et al. J Clin Epidemiol. 2014 Sep;67(9):1035-43. doi: 10.1016/j.jclinepi.2014.04.005. Epub 2014 May 15. J Clin Epidemiol. 2014. PMID: 24837298 Free PMC article. Clinical Trial.
STUDY DESIGN AND SETTING: The data consist of EQ-5D scores for 565 pairs of care home residents and proxies and quality-adjusted life-years (QALYs) for 248 pairs. Cluster-adjusted agreement was compared for the domains, index scores, and QALYs from the EQ-5D. Factor …
STUDY DESIGN AND SETTING: The data consist of EQ-5D scores for 565 pairs of care home residents and proxies and quality-adjusted life …
Health- Related Quality of Life for Multiple Myeloma Patients with Bone Metastases in Indonesia: A Cross-Sectional Study.
Sayuti NA, Andayani TM, Endarti D, Taroeno-Hariadi KW. Sayuti NA, et al. Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3161-3166. doi: 10.31557/APJCP.2019.20.10.3161. Asian Pac J Cancer Prev. 2019. PMID: 31653168 Free PMC article.
Therefore, this study aimed to describe the HRQoL of MM patients with bone metastases, using The EuroQol five-dimension five levels (EQ -5D-5L) in Indonesia. METHODS: a cross-sectional, multicenter study for MM patients with bone metastases (aged over 18 years old) that co …
Therefore, this study aimed to describe the HRQoL of MM patients with bone metastases, using The EuroQol five-dimension five levels (EQ - …
Early response to therapy and survival in multiple myeloma.
Schaar CG, Kluin-Nelemans JC, le Cessie S, Franck PF, te Marvelde MC, Wijermans PW. Schaar CG, et al. Br J Haematol. 2004 Apr;125(2):162-6. doi: 10.1111/j.1365-2141.2004.04884.x. Br J Haematol. 2004. PMID: 15059138 Free article. Clinical Trial.
An obvious survival advantage was seen for patients who had an M-protein decrease of at least 30% after the first MP cycle, which became significant when an M-protein decrease of 40% or more was reached. As established prognostic parameters (Salmon & Durie stage, serum …
An obvious survival advantage was seen for patients who had an M-protein decrease of at least 30% after the first MP cycle, which became sig …
34 results